Antimicrobial peptides and proteins in Alzheimer's and Parkinson's diseases: implications for biomarker exploration.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Antimicrobial peptides and proteins in Alzheimer's and Parkinson's diseases: implications for biomarker exploration.
- Published In:
- Reviews in the neurosciences, 36(8), 849-879 (2025)
- Authors:
- Yong, Shin Jie, Teoh, Seong Lin, Parhar, Ishwar S, Soga, Tomoko, Lim, Wei Ling, Chew, Jactty
- Database ID:
- RPEP-14385
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14385APA
Yong, Shin Jie; Teoh, Seong Lin; Parhar, Ishwar S; Soga, Tomoko; Lim, Wei Ling; Chew, Jactty. (2025). Antimicrobial peptides and proteins in Alzheimer's and Parkinson's diseases: implications for biomarker exploration.. Reviews in the neurosciences, 36(8), 849-879. https://doi.org/10.1515/revneuro-2025-0034
MLA
Yong, Shin Jie, et al. "Antimicrobial peptides and proteins in Alzheimer's and Parkinson's diseases: implications for biomarker exploration.." Reviews in the neurosciences, 2025. https://doi.org/10.1515/revneuro-2025-0034
RethinkPeptides
RethinkPeptides Research Database. "Antimicrobial peptides and proteins in Alzheimer's and Parki..." RPEP-14385. Retrieved from https://rethinkpeptides.com/research/yong-2025-antimicrobial-peptides-and-proteins
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.